Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.
Provencher S, Ferlay C, Alaoui-Slimani K, Devidas A, Lepretre S, de Prijck B, Sebban C, de la Fouchardiere A, Chassagne-Clement C, Ketterer N, Thyss A, Delannoy A, Tilly H, Biron P, Blay JY, Ghesquières H. Provencher S, et al. Among authors: tilly h. Hematol Oncol. 2011 Mar;29(1):10-6. doi: 10.1002/hon.944. Hematol Oncol. 2011. PMID: 21381074
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Lepage E, Gisselbrecht C, Haioun C, Sebban C, Tilly H, Bosly A, Morel P, Herbrecht R, Reyes F, Coiffier B. Lepage E, et al. Among authors: tilly h. Ann Oncol. 1993 Sep;4(8):651-6. doi: 10.1093/oxfordjournals.annonc.a058619. Ann Oncol. 1993. PMID: 7694634 Free article. Clinical Trial.
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
Solal-Céligny P, Brice P, Brousse N, Caspard H, Bastion Y, Haïoun C, Bosly A, Tilly H, Bordessoule D, Sebban C, Harousseau JL, Morel P, Dupas B, Plassart F, Vasile N, Fort N, Leporrier M. Solal-Céligny P, et al. Among authors: tilly h. J Clin Oncol. 1996 Feb;14(2):514-9. doi: 10.1200/JCO.1996.14.2.514. J Clin Oncol. 1996. PMID: 8636765 Clinical Trial.
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.
Guerci A, Lederlin P, Reyes F, Bordessoule D, Sebban C, Tilly H, Kerneis Y, Biron P, Gisselbrecht C, Herbrecht R, Coiffier B. Guerci A, et al. Among authors: tilly h. Ann Oncol. 1996 Nov;7(9):966-9. doi: 10.1093/oxfordjournals.annonc.a010801. Ann Oncol. 1996. PMID: 9006749 Free article.
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.
Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Brière J, Gaulard P, Reyes F. Haioun C, et al. Among authors: tilly h. J Clin Oncol. 1997 Mar;15(3):1131-7. doi: 10.1200/JCO.1997.15.3.1131. J Clin Oncol. 1997. PMID: 9060555 Clinical Trial.
Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Wendum D, Sebban C, Gaulard P, Coiffier B, Tilly H, Cazals D, Boehn A, Casasnovas RO, Bouabdallah R, Jaubert J, Ferrant A, Diebold J, de Mascarel A, Gisselbrecht C. Wendum D, et al. Among authors: tilly h. J Clin Oncol. 1997 Apr;15(4):1654-63. doi: 10.1200/JCO.1997.15.4.1654. J Clin Oncol. 1997. PMID: 9193366
473 results